[Treatment of peyronie's disease with para-aminobenzoacidic potassium (POTOBA) (author's transl)].
A total of 214 urologists treated 2653 cases of Peyronie's Disease with para-aminobenzoacidic potassium (POTOBA). The treatment was successful in 57.3% and unsuccessful in 42.7% of the cases; 246 patients (9.3%) were 'cured. Particular prescriptions intended to increase gastric tolerance and thereby guarantee long-term use of the medication are pointed to as a prerequisite to successful therapy. Practical advice is presented on how to interest patients in carrying out long-term treatment themselves.
D010129:4-Aminobenzoic Acid / Q000627:therapeutic use*; D062365:Aminobenzoates / Q000627:therapeutic use*; D004341:Drug Evaluation; D004387:Dupuytren Contracture / Q000150:complications; D006801:Humans; D008297:Male; D010411:Penile Induration / Q000188:drug therapy*; D011188:Potassium / Q000627:therapeutic use*; D011795:Surveys and Questionnaires
D062365:Aminobenzoates; D011188:Potassium; D010129:4-Aminobenzoic Acid
Zur Behandlung der Induration penis plastica mit para-aminobenzoesaurem Kalium (PABK).